Atlas Trials

Efficacy and Safety of Camrelizumab in Real-World Study

Clinical trial NCT04631146 · UNKNOWN

Trial details

NCT number
NCT04631146
Sponsor
Guangdong Association of Clinical Trials
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer
Start date
2020-11-30
Primary completion
2021-06-30
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.